Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Gilead Sciences, Inc. v. Apotex, Inc. et al
Case Number:
1:20-cv-00189
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Abrams & Bayliss
- Cooley LLP
- Fish & Richardson
- Morris James
- Phillips McLaughlin
- Smith Katzenstein
- Young Conaway
Companies
Sectors & Industries:
-
September 12, 2022
Gilead Settles HIV Drugs Patent Suit On Eve Of Bench Trial
Gilead Sciences Inc. has settled its Delaware patent infringement lawsuit against five generic-drug makers on the eve of trial, inking a deal that calls for the delayed release until at least 2031 of generic alternatives to Gilead's line of medications that slow the progress of HIV infections.
-
September 08, 2022
IP Forecast: DC Circ. To Hear Free Speech Challenge To DMCA
The D.C. Circuit next week will consider a long-simmering constitutional challenge to parts of the Digital Millennium Copyright Act that lawyers at the Electronic Frontier Foundation call "a draconian federal statute that directly restricts [the] ability to speak." Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.